Content
:::
National Taiwan University
Principal Investigator:胡文聰
Project Manager:曲德彥
About the Team
This technology based on cell-density purifies CTC cells in blood, obtaining a high recovery rate of 90%. This system also includes special microfluidic cell isolation technology, auto-fluorescence, auto-image detection and automated single-cell capturing.
Development
Completed circulating tumor cells selection and analysis technology, verified density selection method for capturing blood CTC up to recovery rate of 90%. Established a quality management system for cell purification platform and related reagents.